<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="letter">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Bras Pneumol</journal-id>
      <journal-id journal-id-type="iso-abbrev">J Bras Pneumol</journal-id>
      <journal-title-group>
        <journal-title>Jornal Brasileiro de Pneumologia : Publica&#xE7;a&#x30B;o Oficial da Sociedade Brasileira de Pneumologia e Tisilogia</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1806-3713</issn>
      <issn pub-type="epub">1806-3756</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Pneumologia e Tisiologia</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">24831409</article-id>
      <article-id pub-id-type="pmc">4083648</article-id>
      <article-id pub-id-type="publisher-id">S1806-37132014000200203</article-id>
      <article-id pub-id-type="doi">10.1590/S1806-37132014000200018</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Letter To The Editor</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Extracorporeal membrane oxygenation for postpneumonectomy
ARDS</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Saueressig</surname>
            <given-names>Maur&#xED;cio Guidi</given-names>
          </name>
          <role>Adjunct Professor</role>
          <aff>Department of Surgery, Porto Alegre Hospital de Cl&#xED;nicas, Federal University of
Rio Grande do Sul School of Medicine, Porto Alegre,
<country>Brazil</country></aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Schwarz</surname>
            <given-names>Patr&#xED;cia</given-names>
          </name>
          <role>Intensivist</role>
          <aff>Department of Intensive Care, Porto Alegre Hospital de Cl&#xED;nicas, Federal
University of Rio Grande do Sul School of Medicine, Porto Alegre,
<country>Brazil</country></aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Schlatter</surname>
            <given-names>Rosane</given-names>
          </name>
          <role>Doctoral Student</role>
          <aff>Graduate Program in Cardiology and Cardiovascular Sciences, Federal University
of Rio Grande do Sul School of Medicine, Porto Alegre,
<country>Brazil</country></aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Moreschi</surname>
            <given-names>Alexandre Heitor</given-names>
          </name>
          <role>Physician</role>
          <aff>Department of Thoracic Surgery, Porto Alegre Hospital de Cl&#xED;nicas, Federal
University of Rio Grande do Sul School of Medicine, Porto Alegre,
<country>Brazil</country></aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wender</surname>
            <given-names>Orlando Carlos Belmonte</given-names>
          </name>
          <role>Adjunct Professor</role>
          <aff>Department of Surgery, Porto Alegre Hospital de Cl&#xED;nicas, Federal University of
Rio Grande do Sul School of Medicine, Porto Alegre,
<country>Brazil</country></aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>de Macedo-Neto</surname>
            <given-names>Amarilio Vieira</given-names>
          </name>
          <role>Adjunct Professor</role>
          <aff>Department of Surgery, Porto Alegre Hospital de Cl&#xED;nicas, Federal University of
Rio Grande do Sul School of Medicine, Porto Alegre,
<country>Brazil</country></aff>
        </contrib>
      </contrib-group>
      <pub-date pub-type="epub-ppub">
        <season>Mar-Apr</season>
        <year>2014</year>
      </pub-date>
      <!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' -->
      <pub-date pub-type="ppub">
        <season>Mar-Apr</season>
        <year>2014</year>
      </pub-date>
      <volume>40</volume>
      <issue>2</issue>
      <fpage>203</fpage>
      <lpage>206</lpage>
      <history>
        <date date-type="received">
          <day>25</day>
          <month>9</month>
          <year>2013</year>
        </date>
        <date date-type="accepted">
          <day>15</day>
          <month>10</month>
          <year>2013</year>
        </date>
      </history>
      <permissions>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative
Commons Attribution Non-Commercial License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the
original work is properly cited.</license-p>
        </license>
      </permissions>
      <counts>
        <fig-count count="1"/>
        <table-count count="1"/>
        <ref-count count="9"/>
        <page-count count="4"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>To the Editor:</title>
      <p>Although ARDS is an uncommon complication of pneumonectomy, the associated mortality is
high (ranging from 50% to 100%).<sup>(</sup>
<xref rid="B01" ref-type="bibr">
<sup>1</sup>
</xref>
<sup>)</sup> Here, we report the case of a patient with postpneumonectomy ARDS that was
satisfactorily managed by extracorporeal membrane oxygenation (ECMO). A 31-year-old
White female patient diagnosed with cystic fibrosis 10 years prior presented with
recurrent pneumonia secondary to bronchiectasis, predominantly in the left lung (<xref ref-type="fig" rid="f01">Figure 1A</xref>). In the last two years, despite continuous
use of antibiotics (500 mg of azithromycin p.o. three times a week), the patient had had
seven respiratory infections, as well as purulent sputum between episodes. Therefore, a
decision was made to perform a left pneumonectomy. The postoperative course was
satisfactory. However, on postoperative day 2, the patient showed dyspnea, cough with
purulent sputum, tachypnea, left-sided chest pain, inspiratory rales in the lower lung
fields, and hypoxemia (SaO<sub>2</sub> &lt; 70%). Initial management with noninvasive
ventilation was ineffective, the patient being therefore placed on mechanical
ventilation on postoperative day 3 (<xref ref-type="fig" rid="f01">Figure 1B</xref>).
After 17 h of mechanical ventilation, she still had ARDS, hypoxemia, and a pH &lt; 7.2,
despite alveolar recruitment maneuvers, attempts to reduce tidal volume, oxygen
insufflation into the trachea, and neuromuscular blockade (<xref ref-type="table" rid="t01">Table 1</xref>). Therefore, a decision was made to place her on venovenous
ECMO (a Revolution<sup>TM</sup> centrifugal pump and an EOS ECMO adult membrane
oxygenator; Sorin, Milan, Italy). Percutaneous cannulation of the femoral and jugular
veins was performed by the Seldinger technique, a 19-F arterial cannula being inserted
into the right internal jugular vein for reinfusion and a 29-F venous cannula being
inserted into the right femoral vein for drainage (Maquet, Rastatt, Germany).
Venipuncture and cannulation of the jugular and femoral veins were performed under
ultrasound guidance at the bedside. Continuous i.v. infusion of unfractionated heparin
was used in order to achieve an activated clotting time of 160-200 s. Initially, ECMO
blood flow was 60 mL . kg<sup>-1</sup> . min<sup>-1</sup>, being subsequently adjusted
to maintain a PaO<sub>2</sub> &gt; 50 mmHg, whereas gas flow (sweep gas) was titrated to
maintain a pH = 7.3. The temperature of the patient remained at 35.5-36.5&#xB0;C. Lung rest
was achieved by pressure-controlled ventilation at protective ventilator settings (i.e.,
a plateau pressure = 25 cmH<sub>2</sub>O, a positive end-expiratory pressure of 5-15
cmH<sub>2</sub>O, and an FiO<sub>2</sub> = 0.4). The patient showed progressive
radiological improvement (<xref ref-type="fig" rid="f01">Figure 1C</xref>), as well as
progressive improvement in arterial blood gas parameters and lung compliance, meeting
the criteria for weaning on ECMO day 5 (<xref ref-type="table" rid="t01">Table
1</xref>). Three hours later, she was successfully extubated. The patient was discharged
on postadmission day 21. There were no hemorrhagic or thromboembolic complications of
ECMO. The total cost of ECMO, in Brazilian reals (R$), was 33,470.16, R$ 26,315.00
having been spent on the ECMO circuit plus medical supplies (including cannulae), R$
5,594.93 having been spent on the ICU stay, and R$ 1,560.23 having been spent on
diagnostic tests. However, the amount paid by the <italic>Sistema &#xDA;nico de
Sa&#xFA;de</italic> (SUS, Brazilian Unified Health Care System) via the Authorized
Hospital Admissions system was R$ 5,917.88.</p>
      <p>
<fig id="f01" orientation="portrait" position="float"><label>Figure 1</label><caption><title>Chest X-rays showing the progression of the patient. In A, chest X-ray
taken before pneumonectomy, showing extensive bronchiectasis, reduced lung
volume, and left pleural thickening. In B, chest X-ray taken on postoperative
day 3, showing extensive areas of consolidation on the right and the
postpneumonectomy pleural space on the left. In C, chest X-ray taken on the day
of weaning from extracorporeal membrane oxygenation (i.e., on postoperative day
8), showing resolution of the right-sided consolidation. Note the venous
cannulae and their ends in the right atrium (for reinfusion) and in the
intrahepatic portion of the inferior vena cava (for drainage). In D, chest
X-ray taken three months after hospital discharge, showing nearly complete
closure of the pneumonectomy cavity.</title></caption><graphic xlink:href="1806-3713-jbpneu-40-02-00203-gf01"/></fig>
</p>
      <p>
<table-wrap id="t01" orientation="portrait" position="float"><label>Table 1</label><caption><title>Clinical status before initiation of and on the day of weaning from
extracorporeal membrane oxygenation.</title></caption><table frame="hsides" rules="groups" style="border-top: 1px solid black; border-bottom: 1px solid black; width: 90%"><colgroup span="1"><col width="10%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/></colgroup><thead style="border-bottom: 1px solid black"><tr><th rowspan="1" colspan="1"> Arterial blood gas results</th><th rowspan="1" colspan="1"> Before ECMO</th><th rowspan="1" colspan="1"> On the day of weaning from ECMO</th></tr></thead><tbody><tr><td rowspan="1" colspan="1"> pH</td><td rowspan="1" colspan="1"> 7</td><td rowspan="1" colspan="1"> 7.5</td></tr><tr><td rowspan="1" colspan="1"> PaO<sub>2</sub>, mmHg</td><td rowspan="1" colspan="1"> 108</td><td rowspan="1" colspan="1"> 136</td></tr><tr><td rowspan="1" colspan="1"> PaCO<sub>2</sub>, mmHg</td><td rowspan="1" colspan="1"> 115</td><td rowspan="1" colspan="1"> 57</td></tr><tr><td rowspan="1" colspan="1"> PaO<sub>2</sub>/FiO<sub>2</sub>
</td><td rowspan="1" colspan="1"> 107</td><td rowspan="1" colspan="1"> 388</td></tr><tr><td rowspan="1" colspan="1"> Mechanical ventilation</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"> PEEP, cmH<sub>2</sub>O</td><td rowspan="1" colspan="1"> 8</td><td rowspan="1" colspan="1"> 6</td></tr><tr><td rowspan="1" colspan="1"> FiO<sub>2</sub>
</td><td rowspan="1" colspan="1"> 1.00</td><td rowspan="1" colspan="1"> 0.35</td></tr><tr><td rowspan="1" colspan="1"> RR, breaths/min</td><td rowspan="1" colspan="1"> 28</td><td rowspan="1" colspan="1"> 15</td></tr><tr><td rowspan="1" colspan="1"> Tidal volume/ideal weight, mL/kg</td><td rowspan="1" colspan="1"> 4.4</td><td rowspan="1" colspan="1"> 5.8</td></tr><tr><td rowspan="1" colspan="1"> Plateau pressure, cmH<sub>2</sub>O</td><td rowspan="1" colspan="1"> 35</td><td rowspan="1" colspan="1"> 22</td></tr><tr><td rowspan="1" colspan="1"> Peak inspiratory pressure,
cmH<sub>2</sub>O</td><td rowspan="1" colspan="1"> 45</td><td rowspan="1" colspan="1"> 26</td></tr><tr><td rowspan="1" colspan="1"> Static lung compliance,
mL/cmH<sub>2</sub>O</td><td rowspan="1" colspan="1"> 9</td><td rowspan="1" colspan="1"> 20</td></tr><tr><td rowspan="1" colspan="1"> Hemodynamics</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"> Norepinephrine, &#x3BC;g . kg<sup>-1</sup> .
min<sup>-1</sup>
</td><td rowspan="1" colspan="1"> 0.16</td><td rowspan="1" colspan="1"> 0.00</td></tr><tr><td rowspan="1" colspan="1"> Mean arterial pressure, mmHg</td><td rowspan="1" colspan="1"> 66</td><td rowspan="1" colspan="1"> 90</td></tr><tr><td rowspan="1" colspan="1"> HR, bpm</td><td rowspan="1" colspan="1"> 90</td><td rowspan="1" colspan="1"> 80</td></tr><tr><td rowspan="1" colspan="1"> Serum test results</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"> Lactate, mmol/L</td><td rowspan="1" colspan="1"> 0.4</td><td rowspan="1" colspan="1"> 0.9</td></tr><tr><td rowspan="1" colspan="1"> Base excess, mmol/L</td><td rowspan="1" colspan="1"> -3.5</td><td rowspan="1" colspan="1"> 17.0</td></tr><tr><td rowspan="1" colspan="1"> C-reactive protein, mg/L</td><td rowspan="1" colspan="1"> 231</td><td rowspan="1" colspan="1"> 17</td></tr><tr><td rowspan="1" colspan="1"> Hemoglobin, g/dL</td><td rowspan="1" colspan="1"> 10</td><td rowspan="1" colspan="1"> 9</td></tr><tr><td rowspan="1" colspan="1"> Sedation/neuromuscular blockade/scores</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"> Midazolam, mg . kg<sup>-1</sup> .
h<sup>-1</sup>
</td><td rowspan="1" colspan="1"> 0.2</td><td rowspan="1" colspan="1"> 0</td></tr><tr><td rowspan="1" colspan="1"> Fentanyl, &#x3BC;g . kg<sup>-1</sup> . h<sup>-1</sup>
</td><td rowspan="1" colspan="1"> 4</td><td rowspan="1" colspan="1"> 2</td></tr><tr><td rowspan="1" colspan="1"> Atracurium, mg . kg<sup>-1</sup> .
h<sup>-1</sup>
</td><td rowspan="1" colspan="1"> 0.6</td><td rowspan="1" colspan="1"> 0.0</td></tr><tr><td rowspan="1" colspan="1"> SOFA score</td><td rowspan="1" colspan="1"> 14</td><td rowspan="1" colspan="1"> 7</td></tr><tr><td rowspan="1" colspan="1"> Murray score</td><td rowspan="1" colspan="1"> 3.0</td><td rowspan="1" colspan="1"> 1.2</td></tr></tbody></table><table-wrap-foot><fn id="TFN01t01"><label>ECMO</label><p>: extracorporeal membrane oxygenation</p></fn><fn id="TFN02t01"><label>PEEP</label><p>: positive end-expiratory pressure</p></fn><fn id="TFN03t01"><label>SOFA</label><p>: Sequential Organ Failure Assessment</p></fn></table-wrap-foot></table-wrap>
</p>
      <p>The incidence of ARDS after left pneumonectomy is approximately 4%.<sup>(</sup>
<xref rid="B02" ref-type="bibr">
<sup>2</sup>
</xref>
<sup>)</sup> Possible triggers include reduced lymphatic drainage and single-lung
ventilation with hyperoxia.<sup>(</sup>
<xref rid="B03" ref-type="bibr">
<sup>3</sup>
</xref>
<sup>)</sup> Supportive care consists of mechanical ventilation; however, in cases of
refractory hypoxemia, rescue therapies include prone positioning<sup>(</sup>
<xref rid="B04" ref-type="bibr">
<sup>4</sup>
</xref>
<sup>)</sup> and ECMO.<sup>(</sup>
<xref rid="B05" ref-type="bibr">
<sup>5</sup>
</xref>
<sup>)</sup>
</p>
      <p>An invasive method, ECMO corrects severe hypoxemia and hypercapnia (pH = 7.2) and
reduces FiO<sub>2</sub> (&lt; 0.5) and plateau pressure to safer levels, allowing the
lung to rest in cases of ARDS.<sup>(</sup>
<xref rid="B06" ref-type="bibr">
<sup>6</sup>
</xref>
<sup>,</sup>
<xref rid="B07" ref-type="bibr">
<sup>7</sup>
</xref>
<sup>)</sup> Despite a PaO<sub>2</sub>/FiO<sub>2</sub> ratio &gt; 100 mmHg, early ECMO
was recommended because of the presence of an FiO<sub>2</sub> &gt; 0.8, a plateau
pressure &gt; 30 cmH<sub>2</sub>O, a pH &lt; 7.2, and a PaCO<sub>2</sub> &gt; 100 mmHg
in our patient. In addition, her Sequential Organ Failure Assessment score was 14,
indicating the absence of multiorgan involvement and showing that the ECMO team at the
Porto Alegre <italic>Hospital de Cl&#xED;nicas</italic>, located in the city of Porto Alegre,
Brazil, abides by the policy that ARDS patients who are not at risk of imminent death
should be recognized as candidates for ECMO. This approach has been advocated by other
ECMO teams in Brazil.<sup>(</sup>
<xref rid="B08" ref-type="bibr">
<sup>8</sup>
</xref>
<sup>,</sup>
<xref rid="B09" ref-type="bibr">
<sup>9</sup>
</xref>
<sup>)</sup>
</p>
      <p>A novel technique, ECMO is currently not covered by the SUS; the reimbursement that our
hospital received from the SUS covered less than 20% of the actual costs. Therefore,
there is a need for an economic evaluation of ECMO in Brazil in order to inform the
decision of whether ECMO should be included in the range of procedures covered by the
SUS.</p>
      <p>On the basis of the case reported here, we recommend early rescue therapy with
venovenous ECMO for patients with postpneumonectomy ARDS accompanied by hypoxemia and
respiratory acidosis refractory to mechanical ventilation, provided that the medical
team has sufficient experience with the procedure, which is complex and costly.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="B01">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dulu</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Pastores</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Riedel</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Rusch</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Halpern</surname>
              <given-names>NA</given-names>
            </name>
          </person-group>
          <article-title>Prevalence and mortality of acute lung injury and ARDS
after lung resection</article-title>
          <source>Chest</source>
          <year>2006</year>
          <volume>130</volume>
          <issue>1</issue>
          <fpage>73</fpage>
          <lpage>78</lpage>
          <pub-id pub-id-type="pmid">16840385</pub-id>
        </element-citation>
      </ref>
      <ref id="B02">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Waller</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Gebitekin</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Saunders</surname>
              <given-names>NR</given-names>
            </name>
            <name>
              <surname>Walker</surname>
              <given-names>DR</given-names>
            </name>
          </person-group>
          <article-title>Noncardiogenic pulmonary edema complicating lung
resection</article-title>
          <source>Ann Thorac Surg</source>
          <year>1993</year>
          <volume>55</volume>
          <issue>1</issue>
          <fpage>140</fpage>
          <lpage>143</lpage>
          <pub-id pub-id-type="doi">10.1016/0003-4975(93)90490-9</pub-id>
          <pub-id pub-id-type="pmid">8417662</pub-id>
        </element-citation>
      </ref>
      <ref id="B03">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hyde</surname>
              <given-names>BR</given-names>
            </name>
            <name>
              <surname>Woodside</surname>
              <given-names>KJ</given-names>
            </name>
          </person-group>
          <article-title>Postoperative acute respiratory distress syndrome
development in the thoracic surgery patient</article-title>
          <source>Semin Thorac Cardiovasc Surg</source>
          <year>2006</year>
          <volume>18</volume>
          <issue>1</issue>
          <fpage>28</fpage>
          <lpage>34</lpage>
          <pub-id pub-id-type="doi">10.1053/j.semtcvs.2005.12.002</pub-id>
          <pub-id pub-id-type="pmid">16766250</pub-id>
        </element-citation>
      </ref>
      <ref id="B04">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gu&#xE9;rin</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Reignier</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Richard</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Beuret</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Gacouin</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Boulain</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Prone positioning in severe acute respiratory distress
syndrome</article-title>
          <source>N Engl J Med</source>
          <year>2013</year>
          <volume>368</volume>
          <issue>23</issue>
          <fpage>2159</fpage>
          <lpage>2168</lpage>
          <pub-id pub-id-type="doi">10.1056/NEJMoa1214103</pub-id>
          <pub-id pub-id-type="pmid">23688302</pub-id>
        </element-citation>
      </ref>
      <ref id="B05">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Peek</surname>
              <given-names>GJ</given-names>
            </name>
            <name>
              <surname>Mugford</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Tiruvoipati</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Wilson</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Allen</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Thalanany</surname>
              <given-names>MM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Efficacy and economic assessment of conventional
ventilatory support versus extracorporeal membrane oxygenation for severe adult
respiratory failure (CESAR): a multicentre randomised controlled
trial</article-title>
          <source>Lancet</source>
          <year>2009</year>
          <volume>374</volume>
          <issue>9698</issue>
          <fpage>1351</fpage>
          <lpage>1363</lpage>
          <pub-id pub-id-type="doi">10.1016/S0140-6736(09)61069-2</pub-id>
          <pub-id pub-id-type="pmid">19762075</pub-id>
        </element-citation>
      </ref>
      <ref id="B06">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brower</surname>
              <given-names>RG</given-names>
            </name>
            <name>
              <surname>Ware</surname>
              <given-names>LB</given-names>
            </name>
            <name>
              <surname>Berthiaume</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Matthay</surname>
              <given-names>MA</given-names>
            </name>
          </person-group>
          <article-title>Treatment of ARDS</article-title>
          <source>Chest</source>
          <year>2001</year>
          <volume>120</volume>
          <issue>4</issue>
          <fpage>1347</fpage>
          <lpage>1367</lpage>
          <pub-id pub-id-type="doi">10.1378/chest.120.4.1347</pub-id>
          <pub-id pub-id-type="pmid">11591581</pub-id>
        </element-citation>
      </ref>
      <ref id="B07">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Terragni</surname>
              <given-names>PP</given-names>
            </name>
            <name>
              <surname>Rosboch</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Tealdi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Corno</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Menaldo</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Davini</surname>
              <given-names>O</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Tidal hyperinflation during low tidal volume ventilation
in acute respiratory distress syndrome</article-title>
          <source>Am J Respir Crit Care Med</source>
          <year>2007</year>
          <volume>175</volume>
          <issue>2</issue>
          <fpage>160</fpage>
          <lpage>166</lpage>
          <pub-id pub-id-type="doi">10.1164/rccm.200607-915OC</pub-id>
          <pub-id pub-id-type="pmid">17038660</pub-id>
        </element-citation>
      </ref>
      <ref id="B08">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Park</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Azevedo</surname>
              <given-names>LC</given-names>
            </name>
            <name>
              <surname>Mendes</surname>
              <given-names>PV</given-names>
            </name>
            <name>
              <surname>Carvalho</surname>
              <given-names>CR</given-names>
            </name>
            <name>
              <surname>Amato</surname>
              <given-names>MB</given-names>
            </name>
            <name>
              <surname>Schettino</surname>
              <given-names>GP</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>First-year experience of a Brazilian tertiary medical
center in supporting severely ill patients using extracorporeal membrane
oxygenation</article-title>
          <source>Clinics (Sao Paulo)</source>
          <year>2012</year>
          <volume>67</volume>
          <issue>10</issue>
          <fpage>1157</fpage>
          <lpage>1163</lpage>
          <pub-id pub-id-type="doi">10.6061/clinics/2012(10)07</pub-id>
          <pub-id pub-id-type="pmid">23070342</pub-id>
        </element-citation>
      </ref>
      <ref id="B09">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Azevedo</surname>
              <given-names>LC</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Costa</surname>
              <given-names>EL</given-names>
            </name>
            <name>
              <surname>Santos</surname>
              <given-names>EV</given-names>
            </name>
            <name>
              <surname>Hirota</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Taniguchi</surname>
              <given-names>LU</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Extracorporeal membrane oxygenation in severe hypoxemia:
time for reappraisal?</article-title>
          <source>J Bras Pneumol</source>
          <year>2012</year>
          <volume>38</volume>
          <issue>1</issue>
          <fpage>7</fpage>
          <lpage>12</lpage>
          <pub-id pub-id-type="pmid">22407035</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <sub-article id="S01" article-type="translation" xml:lang="pt">
    <front-stub>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Cartas Ao Editor</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Oxigena&#xE7;&#xE3;o extracorp&#xF3;rea por membrana no tratamento da SARA
p&#xF3;s-pneumonectomia</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Saueressig</surname>
            <given-names>Maur&#xED;cio Guidi</given-names>
          </name>
          <role>Professor Adjunto</role>
          <aff>Departamento de Cirurgia, Hospital de Cl&#xED;nicas de Porto Alegre, Faculdade de
Medicina, Universidade Federal do Rio Grande do Sul, Porto Alegre (RS)
<country>Brasil</country></aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Schwarz</surname>
            <given-names>Patr&#xED;cia</given-names>
          </name>
          <role>M&#xE9;dica Intensivista</role>
          <aff>Servi&#xE7;o de Medicina Intensiva, Hospital de Cl&#xED;nicas de Porto Alegre, Faculdade
de Medicina, Universidade Federal do Rio Grande do Sul, Porto Alegre (RS)
<country>Brasil</country></aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Schlatter</surname>
            <given-names>Rosane</given-names>
          </name>
          <role>Doutoranda</role>
          <aff>Programa de P&#xF3;s-Gradua&#xE7;&#xE3;o em Cardiologia e Ci&#xEA;ncias Cardiovasculares, Faculdade
de Medicina, Universidade Federal do Rio Grande do Sul, Porto Alegre (RS)
<country>Brasil</country></aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Moreschi</surname>
            <given-names>Alexandre Heitor</given-names>
          </name>
          <role>M&#xE9;dico</role>
          <aff>Servi&#xE7;o de Cirurgia Tor&#xE1;cica, Hospital de Cl&#xED;nicas de Porto Alegre, Faculdade de
Medicina, Universidade Federal do Rio Grande do Sul, Porto Alegre (RS)
<country>Brasil</country></aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wender</surname>
            <given-names>Orlando Carlos Belmonte</given-names>
          </name>
          <role>Professor Adjunto</role>
          <aff>Departamento de Cirurgia, Hospital de Cl&#xED;nicas de Porto Alegre, Faculdade de
Medicina, Universidade Federal do Rio Grande do Sul, Porto Alegre (RS)
<country>Brasil</country></aff>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Macedo-Neto</surname>
            <given-names>Amarilio Vieira de</given-names>
          </name>
          <role>Professor Adjunto</role>
          <aff>Departamento de Cirurgia, Hospital de Cl&#xED;nicas de Porto Alegre, Faculdade de
Medicina, Universidade Federal do Rio Grande do Sul, Porto Alegre (RS)
<country>Brasil</country></aff>
        </contrib>
      </contrib-group>
    </front-stub>
    <body>
      <sec>
        <title>Ao Editor:</title>
        <p>A SARA p&#xF3;s-pneumonectomia &#xE9; uma complica&#xE7;&#xE3;o infrequente, por&#xE9;m com alta mortalidade
(de 50% at&#xE9; 100%).<sup>(</sup>
<xref rid="B01" ref-type="bibr">
<sup>1</sup>
</xref>
<sup>)</sup> Gostar&#xED;amos de relatar um caso manejado satisfatoriamente com
<italic>extracorporeal membrane oxygenation</italic> (ECMO, oxigena&#xE7;&#xE3;o
extracorp&#xF3;rea por membrana). Uma mulher branca de 31 anos, com diagn&#xF3;stico de fibrose
c&#xED;stica havia 10 anos, apresentava pneumonias repetidas e secund&#xE1;rias a
bronquiectasias que predominavam no pulm&#xE3;o esquerdo (<xref ref-type="fig" rid="f02">Figura 1A</xref>). Nos &#xFA;ltimos dois anos, apesar do uso ininterrupto de
antibi&#xF3;tico (azitromicina, 500 mg v.o., tr&#xEA;s vezes por semana), apresentou sete
infec&#xE7;&#xF5;es respirat&#xF3;rias, al&#xE9;m de escarro purulento entre essas exacerba&#xE7;&#xF5;es. Dessa
maneira, decidiu-se pela pneumonectomia esquerda. A evolu&#xE7;&#xE3;o foi satisfat&#xF3;ria at&#xE9; o
2&#xBA; dia de p&#xF3;s-operat&#xF3;rio (PO), quando ela iniciou com dispneia, tosse com escarro
purulento, taquipneia, dor tor&#xE1;cica em hemit&#xF3;rax &#xE0; esquerda, estertores
teleinspirat&#xF3;rios em campo pulmonar inferior e hipoxemia (SaO<sub>2</sub> &lt; 70%).
O manejo inicial com ventila&#xE7;&#xE3;o n&#xE3;o invasiva foi ineficaz, o que levou &#xE0; instala&#xE7;&#xE3;o
de ventila&#xE7;&#xE3;o mec&#xE2;nica (VM) no 3&#xBA; PO (<xref ref-type="fig" rid="f02">Figura
1B</xref>). Ap&#xF3;s 17 h de VM, a paciente mantinha-se com SARA, com hipoxemia e pH &lt;
7,2, apesar das manobras de recrutamento alveolar, tentativas de redu&#xE7;&#xE3;o do volume
corrente, insufla&#xE7;&#xE3;o de oxig&#xEA;nio pela traqueia e bloqueio neuromuscular (<xref ref-type="table" rid="t02">Tabela 1</xref>). Assim, foi indicada a coloca&#xE7;&#xE3;o da
ECMO venovenosa (bomba centr&#xED;fuga Revolution<sup>TM</sup> e oxigenador adulto EOS
ECMO; Sorin, Mil&#xE3;o, It&#xE1;lia) com canula&#xE7;&#xE3;o femorojugular percut&#xE2;nea pela t&#xE9;cnica de
Seldinger - c&#xE2;nula arterial 19 F na veia jugular interna direita como via de
reinfus&#xE3;o; c&#xE2;nula venosa 29 F na veia femoral direita como via de drenagem (Maquet,
Rastatt, Alemanha). As pun&#xE7;&#xF5;es venosas e o posicionamento intravascular das c&#xE2;nulas
foram realizados sob orienta&#xE7;&#xE3;o ecogr&#xE1;fica &#xE0; beira do leito. Definimos o tempo de
coagula&#xE7;&#xE3;o ativada entre 160 e 200 segundos atrav&#xE9;s de heparina n&#xE3;o fracionada em
infus&#xE3;o cont&#xED;nua i.v. O fluxo de sangue da ECMO, que inicialmente era de 60 mL .
kg<sup>-1</sup> . min<sup>-1</sup>, foi posteriormente ajustado para manter a
PaO<sub>2</sub> &gt; 50 mmHg, enquanto o fluxo de g&#xE1;s (<italic>sweep gas</italic>)
foi titulado a fim de sustentar um pH = 7,3. A temperatura da paciente permaneceu de
35,5-36,5&#xB0;C. No mesmo momento, iniciamos o repouso pulmonar a partir da VM sob
press&#xE3;o controlada com par&#xE2;metros protetores (press&#xE3;o de plat&#xF4; = 25 cmH<sub>2</sub>O,
press&#xE3;o expirat&#xF3;ria final positiva de 5-15 cmH<sub>2</sub>O e FiO<sub>2</sub> = 0,4).
A paciente apresentou melhora radiol&#xF3;gica (<xref ref-type="fig" rid="f02">Figura
1C</xref>), gasom&#xE9;trica e da complac&#xEA;ncia pulmonar progressivamente e, no 5&#xBA; dia
de suporte extracorp&#xF3;reo, preencheu os crit&#xE9;rios de desmame da ECMO (<xref ref-type="table" rid="t02">Tabela 1</xref>). Tr&#xEA;s horas ap&#xF3;s, foi extubada com
sucesso. A alta hospitalar ocorreu 21 dias ap&#xF3;s a interna&#xE7;&#xE3;o. N&#xE3;o houve complica&#xE7;&#xF5;es
hemorr&#xE1;gicas ou tromboemb&#xF3;licas associadas &#xE0; ECMO. Em rela&#xE7;&#xE3;o aos custos preliminares
da ECMO, foram gastos R$ 26.315,00 com o circuito de oxigena&#xE7;&#xE3;o extracorp&#xF3;reo,
c&#xE2;nulas e materiais m&#xE9;dico-hospitalares; R$ 5.594,93 com di&#xE1;rias do CTI; e R$
1.560,23 com exames diagn&#xF3;sticos. O total gasto foi de R$ 33.470,16. No entanto,
verificou-se que o valor faturado pela autoriza&#xE7;&#xE3;o de interna&#xE7;&#xE3;o hospitalar do
Sistema &#xDA;nico de Sa&#xFA;de (SUS) consistiu em apenas R$ 5.917,88.</p>
        <p>
<fig id="f02" orientation="portrait" position="float"><label>Figura 1</label><caption><title>Exames radiol&#xF3;gicos que ilustram a evolu&#xE7;&#xE3;o da paciente. Em A,
radiografia de t&#xF3;rax no pr&#xE9;-operat&#xF3;rio de pneumonectomia, com extensas
bronquiectasias, redu&#xE7;&#xE3;o de volume pulmonar e espessamento pleural &#xE0;
esquerda. Em B, radiografia no 3&#xBA; dia de p&#xF3;s-operat&#xF3;rio, com extensas
consolida&#xE7;&#xF5;es &#xE0; direita e cavidade pleural de pneumonectomia &#xE0; esquerda. Em
C, radiografia no dia do desmame da oxigena&#xE7;&#xE3;o extracorp&#xF3;rea por membrana,
no 8&#xBA; dia de p&#xF3;s-operat&#xF3;rio, demonstrando regress&#xE3;o das consolida&#xE7;&#xF5;es &#xE0;
direita. Observam-se as c&#xE2;nulas venosas com as respectivas extremidades no
&#xE1;trio direito (linha de reinfus&#xE3;o) e na veia cava inferior na por&#xE7;&#xE3;o
intra-hep&#xE1;tica (linha de drenagem). Em D, radiografia retirada tr&#xEA;s meses
ap&#xF3;s a alta hospitalar, demonstrando a cavidade de pneumonectomia &#xE0; esquerda
quase totalmente obliterada.</title></caption><graphic xlink:href="1806-3713-jbpneu-40-02-00203-gf01-pt"/></fig>
</p>
        <p>
<table-wrap id="t02" orientation="portrait" position="float"><label>Tabela 1</label><caption><title>Condi&#xE7;&#xE3;o cl&#xED;nica antes da implanta&#xE7;&#xE3;o e no dia de retirada da oxigena&#xE7;&#xE3;o
extracorp&#xF3;rea por membrana.</title></caption><table frame="hsides" rules="groups" style="border-top: 1px solid black; border-bottom: 1px solid black; width: 90%"><colgroup span="1"><col width="10%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/><col width="10%" span="1"/></colgroup><thead style="border-bottom: 1px solid black"><tr><th rowspan="1" colspan="1"> Gasometria arterial</th><th rowspan="1" colspan="1"> Pr&#xE9;-ECMO</th><th rowspan="1" colspan="1"> Desmame</th></tr></thead><tbody><tr><td rowspan="1" colspan="1"> pH</td><td rowspan="1" colspan="1"> 7</td><td rowspan="1" colspan="1"> 7,5</td></tr><tr><td rowspan="1" colspan="1"> PaO<sub>2</sub>, mmHg</td><td rowspan="1" colspan="1"> 108</td><td rowspan="1" colspan="1"> 136</td></tr><tr><td rowspan="1" colspan="1"> PaCO<sub>2</sub>, mmHg</td><td rowspan="1" colspan="1"> 115</td><td rowspan="1" colspan="1"> 57</td></tr><tr><td rowspan="1" colspan="1"> PaO<sub>2</sub>/FiO<sub>2</sub>
</td><td rowspan="1" colspan="1"> 107</td><td rowspan="1" colspan="1"> 388</td></tr><tr><td rowspan="1" colspan="1"> Ventila&#xE7;&#xE3;o mec&#xE2;nica</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"> PEEP, cmH<sub>2</sub>O</td><td rowspan="1" colspan="1"> 8</td><td rowspan="1" colspan="1"> 6</td></tr><tr><td rowspan="1" colspan="1"> FiO<sub>2</sub>
</td><td rowspan="1" colspan="1"> 1,00</td><td rowspan="1" colspan="1"> 0,35</td></tr><tr><td rowspan="1" colspan="1"> FR, ciclos/min</td><td rowspan="1" colspan="1"> 28</td><td rowspan="1" colspan="1"> 15</td></tr><tr><td rowspan="1" colspan="1"> Volume corrente/peso ideal, mL/kg</td><td rowspan="1" colspan="1"> 4,4</td><td rowspan="1" colspan="1"> 5,8</td></tr><tr><td rowspan="1" colspan="1"> Press&#xE3;o de plat&#xF4;, cmH<sub>2</sub>O</td><td rowspan="1" colspan="1"> 35</td><td rowspan="1" colspan="1"> 22</td></tr><tr><td rowspan="1" colspan="1"> Press&#xE3;o de pico inspirat&#xF3;rio,
cmH<sub>2</sub>O</td><td rowspan="1" colspan="1"> 45</td><td rowspan="1" colspan="1"> 26</td></tr><tr><td rowspan="1" colspan="1"> Complac&#xEA;ncia pulmonar est&#xE1;tica,
mL/cmH<sub>2</sub>O</td><td rowspan="1" colspan="1"> 9</td><td rowspan="1" colspan="1"> 20</td></tr><tr><td rowspan="1" colspan="1"> Hemodin&#xE2;mica</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"> Noradrenalina, &#x3BC;g . kg<sup>-1</sup> .
min<sup>-1</sup>
</td><td rowspan="1" colspan="1"> 0,16</td><td rowspan="1" colspan="1"> 0,00</td></tr><tr><td rowspan="1" colspan="1"> Press&#xE3;o arterial m&#xE9;dia, mmHg</td><td rowspan="1" colspan="1"> 66</td><td rowspan="1" colspan="1"> 90</td></tr><tr><td rowspan="1" colspan="1"> FC, bpm</td><td rowspan="1" colspan="1"> 90</td><td rowspan="1" colspan="1"> 80</td></tr><tr><td rowspan="1" colspan="1"> Exames s&#xE9;ricos</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"> Lactato, mmol/L</td><td rowspan="1" colspan="1"> 0,4</td><td rowspan="1" colspan="1"> 0,9</td></tr><tr><td rowspan="1" colspan="1"> Excesso de base, mmol/L</td><td rowspan="1" colspan="1"> -3,5</td><td rowspan="1" colspan="1"> 17,0</td></tr><tr><td rowspan="1" colspan="1"> Prote&#xED;na C reativa, mg/L</td><td rowspan="1" colspan="1"> 231</td><td rowspan="1" colspan="1"> 17</td></tr><tr><td rowspan="1" colspan="1"> Hemoglobina, g/dL</td><td rowspan="1" colspan="1"> 10</td><td rowspan="1" colspan="1"> 9</td></tr><tr><td rowspan="1" colspan="1"> Seda&#xE7;&#xE3;o/bloqueio neuromuscular/escores</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"> Midazolam, mg . kg<sup>-1</sup> .
h<sup>-1</sup>
</td><td rowspan="1" colspan="1"> 0,2</td><td rowspan="1" colspan="1"> 0</td></tr><tr><td rowspan="1" colspan="1"> Fentanil, &#x3BC;g . kg<sup>-1</sup> .
h<sup>-1</sup>
</td><td rowspan="1" colspan="1"> 4</td><td rowspan="1" colspan="1"> 2</td></tr><tr><td rowspan="1" colspan="1"> Atrac&#xFA;rio, mg . kg<sup>-1</sup> .
h<sup>-1</sup>
</td><td rowspan="1" colspan="1"> 0,6</td><td rowspan="1" colspan="1"> 0,0</td></tr><tr><td rowspan="1" colspan="1"> SOFA</td><td rowspan="1" colspan="1"> 14</td><td rowspan="1" colspan="1"> 7</td></tr><tr><td rowspan="1" colspan="1"> Escore de Murray</td><td rowspan="1" colspan="1"> 3,0</td><td rowspan="1" colspan="1"> 1,2</td></tr></tbody></table><table-wrap-foot><fn id="TFN01t02"><label>ECMO</label><p>; <italic>extracorporeal membrane oxygenation</italic> (oxigena&#xE7;&#xE3;o
extracorp&#xF3;rea por membrana)</p></fn><fn id="TFN02t02"><label>PEEP</label><p>: <italic>positive end-expiratory pressure</italic> (press&#xE3;o expirat&#xF3;ria
final positiva)</p></fn><fn id="TFN03t02"><label>SOFA</label><p>: <italic>Sequential Organ Failure Assessment</italic>
</p></fn></table-wrap-foot></table-wrap>
</p>
        <p>A incid&#xEA;ncia de SARA ap&#xF3;s a pneumonectomia esquerda &#xE9; de aproximadamente
4%.<sup>(</sup>
<xref rid="B02" ref-type="bibr">
<sup>2</sup>
</xref>
<sup>)</sup> Podemos citar como poss&#xED;veis fatores desencadeantes a redu&#xE7;&#xE3;o da
drenagem linf&#xE1;tica e a ventila&#xE7;&#xE3;o monopulmonar com hiper&#xF3;xia, entre
outros.<sup>(</sup>
<xref rid="B03" ref-type="bibr">
<sup>3</sup>
</xref>
<sup>)</sup> Seu tratamento de suporte &#xE9; centrado na VM; entretanto, nos casos de
hipoxemia refrat&#xE1;ria, m&#xE9;todos como a prona&#xE7;&#xE3;o<sup>(</sup>
<xref rid="B04" ref-type="bibr">
<sup>4</sup>
</xref>
<sup>)</sup> e a ECMO<sup>(</sup>
<xref rid="B05" ref-type="bibr">
<sup>5</sup>
</xref>
<sup>)</sup> surgem como alternativas de resgate.</p>
        <p>A ECMO &#xE9; um m&#xE9;todo invasivo que corrige a hipoxemia grave e a hipercapnia com pH =
7,2, enquanto proporciona redu&#xE7;&#xF5;es da FiO<sub>2</sub> (&lt; 0,5) e da press&#xE3;o de
plat&#xF4; para n&#xED;veis mais seguros, permitindo um maior repouso pulmonar em casos de
SARA.<sup>(</sup>
<xref rid="B06" ref-type="bibr">
<sup>6</sup>
</xref>
<sup>,</sup>
<xref rid="B07" ref-type="bibr">
<sup>7</sup>
</xref>
<sup>)</sup> Em nossa paciente, a presen&#xE7;a de par&#xE2;metros altos de VM (FiO<sub>2</sub>
&gt; 0,8 e press&#xE3;o de plat&#xF4; &gt; 30 cmH<sub>2</sub>O), associada a um pH &lt; 7,2 com
PaCO<sub>2</sub> &gt; 100 mmHg, levaram &#xE0; indica&#xE7;&#xE3;o precoce da ECMO, mesmo que a
rela&#xE7;&#xE3;o PaO<sub>2</sub>/FiO<sub>2</sub> estivesse acima de 100 mmHg. Al&#xE9;m disso, o
valor calculado de 14 para o &#xED;ndice <italic>Sequential Organ Failure
Assessment</italic> reflete a aus&#xEA;ncia de comprometimento multiorg&#xE2;nico de nossa
paciente, demonstrando a pol&#xED;tica da equipe de ECMO do Hospital de Cl&#xED;nicas,
localizado na cidade de Porto Alegre (RS), que busca o reconhecimento precoce de
pacientes com SARA candidatos &#xE0; ECMO que n&#xE3;o se encontrem ainda em eminente risco de
&#xF3;bito. Essa conduta j&#xE1; foi defendida por outros grupos brasileiros de
ECMO.<sup>(</sup>
<xref rid="B08" ref-type="bibr">
<sup>8</sup>
</xref>
<sup>,</sup>
<xref rid="B09" ref-type="bibr">
<sup>9</sup>
</xref>
<sup>)</sup>
</p>
        <p>Em rela&#xE7;&#xE3;o aos custos, a ECMO &#xE9; uma nova tecnologia ainda n&#xE3;o contemplada pelo SUS
que, por sua vez, repassou ao hospital um valor que ressarciu menos de 20% daquele
gasto com o respectivo tratamento. Dessa maneira, percebe-se a necessidade de estudos
de avalia&#xE7;&#xE3;o econ&#xF4;mica da ECMO em nosso meio a fim de sustentar a sua inclus&#xE3;o como
um procedimento pago pelo SUS.</p>
        <p>A partir do presente relato, sugerimos o tratamento de resgate precoce com ECMO
venovenosa de pacientes p&#xF3;s-pneumonectomia que desenvolvem SARA com hipoxemia e
acidose respirat&#xF3;ria refrat&#xE1;rias &#xE0; VM, desde que haja experi&#xEA;ncia suficiente da
equipe m&#xE9;dica na condu&#xE7;&#xE3;o dessa terapia, que ainda &#xE9; complexa e tem alto custo.</p>
      </sec>
    </body>
  </sub-article>
</article>
</pmc-articleset>
